Oculis Holding AG
OCSNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $484.04M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $7.11$34.48
- Volume (live)
- -
- Avg. volume (3M)
- 309.90K
Oculis Holding (OCS) Stock Price & Financial Analysis
Oculis Holding Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $7.90 - $8.05 |
|---|---|
| 52-Week High | $34.48 |
| 52-Week Low | $7.11 |
| Open | $7.93 |
| Volume (last close) | 294.73K |
| Average Volume (3M) | 309.90K |
| Revenue (TTM) | 294.41K |
|---|---|
| Net Income (TTM) | -96.51M |
| Free Cash Flow (TTM) | -80.03M |
| EPS (TTM) | −$1.69 |
| Profit Margin | -32780.20% |
| Operating Margin | -35874.24% |
| Return on Equity (ROE) | -36.32% |
| Debt to Equity | 0.01 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 484.04M |
|---|---|
| Shares Outstanding | 61.27M |
| Price to Sales (P/S) | 1644.10 |
| Price to Book (P/B) | 1.82 |
| EV/EBITDA | -4.43 |
| 50-Day MA | $10.56 |
|---|---|
| 200-Day MA | $19.38 |
| 1-Year Change | −62.11% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Oculis Holding at a Glance
As of the Oct 23, 2026 close, Oculis Holding (OCS) has a market capitalization of $484.04M. The stock trades at 1644.1× sales. Over the trailing twelve months it lost $96.51M on revenue of $294.41K and burned $80.03M of free cash flow. Revenue grew 13.3% year over year.
As of its latest reported balance sheet, it holds $74.65M in cash and securities against $3.08M of debt, a net cash position of $71.57M.
Oculis Holding does not currently pay a dividend.
The share price is down 62.1% over the past year. At $7.90 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $7.11 to $34.48, below its 200-day moving average of $19.38.
Based on 8 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $36.43, 361.1% above the Oct 23, 2026 close.
Frequently Asked Questions About Oculis Holding
What is the current stock price for OCS?
As of the Oct 23, 2026 close, OCS stock trades at $7.90. The 52-week range is $7.11–$34.48, with a day range of $7.90–$8.05.
What is the P/E ratio for OCS?
The P/E ratio (Price-to-Earnings) for OCS is shown in the Key Statistics section. This valuation metric helps compare Oculis Holding AG to industry peers.
Does OCS pay dividends?
Oculis Holding does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for OCS?
Based on ratings from 8 professional analysts over the last 90 days, the consensus for OCS is Buy. The average 12-month price target is $36.43, a 361.1% upside from the Oct 23, 2026 close of $7.90.
What is the market cap of OCS?
As of the Oct 23, 2026 close, Oculis Holding's market capitalization is $484.0M, classifying it as a small-cap company. Oculis Holding operates in the Healthcare sector within the Biotechnology industry.